ATC Group: N05CM Other hypnotics and sedatives

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N05CM in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N05 Psycholeptics
3 N05C Hypnotics and sedatives
4 N05CM Other hypnotics and sedatives

Group N05CM contents

Code Title
N05CM01 Methaqualone
N05CM02 Clomethiazole
N05CM03 Bromisoval
N05CM04 Carbromal
N05CM05 Scopolamine
N05CM06 Propiomazine
N05CM07 Triclofos
N05CM08 Ethchlorvynol
N05CM09 Valerianae radix
N05CM10 Hexapropymate
N05CM11 Bromides
N05CM12 Apronal
N05CM13 Valnoctamide
N05CM15 Methylpentynol
N05CM16 Niaprazine
N05CM18 Dexmedetomidine

Active ingredients in N05CM

Active Ingredient

Clomethiazole has sedative, muscle relaxant and anticonvulsant properties. It is used for hypnosis in elderly and institutionalised patients, for preanaesthetic sedation and especially in the management of withdrawal from ethanol.

Dexmedetomidine is a selective alpha-2 receptor agonist with a broad range of pharmacological properties. It has a sympatholytic effect through decrease of the release of noradrenaline in sympathetic nerve endings. The sedative effects are mediated through decreased firing of locus coeruleus, the predominant noradrenergic nucleus, situated in the brainstem.

Scopolamine is a naturally occurring belladonna alkaloid and has anticholinergic properties. It acts as a competitive antagonist to acetylchloline and other parasympathomimetic agents. Its mechanism of action in the central nervous system in preventing motion sickness has yet to be elucidated. Scopolamine produces classical symptoms of parasympathetic blockade.

Triclofos is a melatonin agonist and has hypnotic and sedative actions similar to those of chloral hydrate, but it is more palatable and causes less gastric irritation. It is converted in the body into an active compound which works in the brain to induce sleepiness. It decreases the time taken to fall asleep and increases sleep duration. It is given by mouth in the short-term management of insomnia.

Valerian is used as a hypnotic, anxiolytic and soothing agent since the oils it contains have a similar effect to benzodiazepines. Its mechanism of action, however, remains largely unknown.

Related product monographs

Document Type Information Source  
 DAYVIGO Film-coated tablet MPI, US: SPL/PLR FDA, National Drug Code (US)
 DEXDOR Concentrate for solution for infusion MPI, EU: SmPC European Medicines Agency (EU)
 DEXISUN Concentrated solution for infusion MPI, Generic Health Products Regulatory Authority (ZA)
 HEMINEVRIN Capsule MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 PRECEDEX Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)
 QUVIVIQ Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)